{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T14:22:15Z","timestamp":1793456535645,"version":"4.5.0"},"reference-count":118,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T00:00:00Z","timestamp":1690416000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>Nitrofurantoin (NF), a wide-spectrum antibiotic accessible since 1953, is utilized widely to treat urinary tract infections as it usually stays active against drug-resistant uropathogen. The use of Nitrofurantoin has increased exponentially since new guidelines have repositioned it as first-line therapy for uncomplicated lower urinary tract infection (UTI). To, although fluoroquinolones are usually used to re-evaluate the first- and second-line therapies for treating uncomplicated UTI, their level of utilization is thought to be inappropriately excessive and will eventually have a detrimental impact; thus, we hypothesize that NF might be the best choice for this condition, because of its low frequency of utilization and its high susceptibility in common UTI pathogens. It can be concluded from this review that NF can be considered as the most effective drug in the treatment of acute urinary infection, but due to the long-term side effects of this drug, especially in elderly patients, it is essential to introduce some criteria for prescribing NF in cases of chronic UTI.<\/jats:p>","DOI":"10.3389\/fcimb.2023.1148603","type":"journal-article","created":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T16:57:15Z","timestamp":1690477035000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":77,"title":["Nitrofurantoin: properties and potential in treatment of urinary tract infection: a narrative review"],"prefix":"10.3389","volume":"13","author":[{"given":"Marzie","family":"Mahdizade Ari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirin","family":"Dashtbin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Ghasemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soheila","family":"Shahroodian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parisa","family":"kiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elnaz","family":"Bafandeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talieh","family":"Darbandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roya","family":"Ghanavati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atieh","family":"Darbandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,7,27]]},"reference":[{"key":"B1","first-page":"5","article-title":"Efficacy of combination of nitrofurantoin with gentamicin, and ciprofloxacin against resistant E. Coli isolated from patients with urinary tract infections: in vitro study","volume":"3","author":"Abd","year":"2014","journal-title":"Mintage J. Pharm. Med. Sci."},{"key":"B2","first-page":"48","article-title":"Uropathogens and their antimicrobial resistance patterns: relationship with urinary tract infections","volume":"13","author":"Ahmed","year":"2019","journal-title":"Int. J. Health Sci. (Qassim)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jpurol.2020.10.004","article-title":"Effect of continuous antibiotic prophylaxis in children with postoperative JJ stents: a prospective randomized study","volume":"17","author":"Akinci","year":"2021","journal-title":"J. Pediatr. Urol."},{"key":"B4","first-page":"177","article-title":"Synergistic and antimicrobial effects of leaves oil (phoenix dactylifera) agonist gram negative bacteria","volume":"11","author":"Al-safi","year":"2020","journal-title":"System. Rev. Pharm."},{"key":"B5","first-page":"244","article-title":"Urinary tract agents: quinolones, nitrofurantoin, and methenamine","volume-title":"Principles and practice of infectious diseases","author":"Andriole","year":"1985"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1752-1947-4-311","article-title":"Autoimmune hepatitis triggered by nitrofurantoin: a case series","volume":"4","author":"Appleyard","year":"2010","journal-title":"J. Med. Case Rep."},{"key":"B7","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.cbi.2019.05.050","article-title":"Synergistic interactions of phytochemicals with antimicrobial agents: potential strategy to counteract drug resistance","volume":"308","author":"Ayaz","year":"2019","journal-title":"Chemico Biol. Interact."},{"key":"B8","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1097\/SPV.0000000000000977","article-title":"Twice-daily nitrofurantoin administration following short-term transurethral catheterization after pelvic reconstructive surgery: a randomized clinical trial","volume":"27","author":"Bastawros","year":"2021","journal-title":"Female Pelvic Med. Reconstr. Surg."},{"key":"B9","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1021\/jm50003a003","article-title":"The reaction of nitrofurans with bacteria\u2013III. reduction of a series of antibacterial nitrofurans (Type b compounds) by aerobacter aerogenes","volume":"1","author":"Beckett","year":"1958","journal-title":"J. Medicinal Chem."},{"key":"B10","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1590\/S0074-02762006000400007","article-title":"Synergism between plant extract and antimicrobial drugs used on staphylococcus aureus diseases","volume":"101","author":"Betoni","year":"2006","journal-title":"Mem\u00f3rias do Instituto Oswaldo Cruz"},{"key":"B11","doi-asserted-by":"publisher","first-page":"i939","DOI":"10.1136\/bmj.i939","article-title":"Global prevalence of antibiotic resistance in paediatric urinary tract infections caused by Escherichia coli and association with routine use of antibiotics in primary care: systematic review and meta-analysis","volume":"352","author":"Bryce","year":"2016","journal-title":"Bmj"},{"key":"B12","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1097\/00007890-199502000-00029","article-title":"Reversible nitrofurantoin-induced chronic active hepatitis and hepatic cirrhosis in a patient awaiting liver transplantation","volume":"59","author":"Burgert","year":"1995","journal-title":"Transplantation"},{"key":"B13","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.cvsm.2018.11.005","article-title":"Urinary tract infection","volume":"49","author":"Byron","year":"2019","journal-title":"Vet. Clin. North Am. Small Anim. Pract."},{"key":"B14","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1159\/000516940","article-title":"Concomitant nitrofurantoin-induced autoimmune hepatitis and interstitial lung disease","volume":"29","author":"Carvalho de Matos","year":"2022","journal-title":"GE Port J. Gastroenterol."},{"key":"B15","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4103\/phrev.phrev_21_17","article-title":"Developing new antimicrobial therapies: are synergistic combinations of plant extracts\/compounds with conventional antibiotics the solution","volume":"11","author":"Cheesman","year":"2017","journal-title":"Pharmacogn. Rev."},{"key":"B16","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/10790268.2018.1488096","article-title":"Long-term prescribing of nitrofurantoin for urinary tract infections (UTI) in veterans with spinal cord injury (SCI)","volume":"42","author":"Chew","year":"2019","journal-title":"J. Spinal Cord Med."},{"key":"B17","first-page":"729","article-title":"Randomised controlled trial of nitrofurantoin versus placebo in the treatment of uncomplicated urinary tract infection in adult women","volume":"52","author":"Christiaens","year":"2002","journal-title":"Br. J. Gen. Pract."},{"key":"B18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/14787210.2020.1705155","article-title":"Antibiotic combination therapy against resistant bacterial infections: synergy, rejuvenation and resistance reduction","volume":"18","author":"Coates","year":"2020","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"B19","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000401065","article-title":"The pharmacokinetics of nitrofurantoin and its related bioavailability","volume":"25","author":"Conklin","year":"1978","journal-title":"Antibiot. Chemother. (1971)"},{"key":"B20","doi-asserted-by":"crossref","first-page":"6867","DOI":"10.1128\/AAC.01481-16","article-title":"Disruption of membrane by colistin kills uropathogenic Escherichia coli persisters and enhances killing of other antibiotics","volume":"60","author":"Cui","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"B21","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/0090-4295(88)90460-8","article-title":"Nitrofurantoin\u2013current concepts","volume":"32","author":"Cunha","year":"1988","journal-title":"Urology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/00006254-198905000-00034","article-title":"Nitrofurantoin: an update","volume":"44","author":"Cunha","year":"1989","journal-title":"Obstet. Gynecol. Surv."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.mcna.2006.07.006","article-title":"New uses for older antibiotics: nitrofurantoin, amikacin, colistin, polymyxin b, doxycycline, and minocycline revisited","volume":"90","author":"Cunha","year":"2006","journal-title":"Med. Clinics North America"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1007\/s10096-017-2911-1","article-title":"Nitrofurantoin safety and effectiveness in treating acute uncomplicated cystitis (AUC) in hospitalized adults with renal insufficiency: antibiotic stewardship implications","volume":"36","author":"Cunha","year":"2017","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1159\/000222031","article-title":"Interactions of fosfomycin with other antibiotics","volume":"23","author":"Daza","year":"1977","journal-title":"Chemotherapy"},{"key":"B26","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1128\/AAC.02099-12","article-title":"Fosfomycin synergy in vitro with amoxicillin, daptomycin, and linezolid against vancomycin-resistant enterococcus faecium from renal transplant patients with infected urinary stents","volume":"57","author":"Descourouez","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"B27","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/s41429-021-00444-z","article-title":"Fosfomycin and nitrofurantoin: classic antibiotics and perspectives","volume":"74","author":"Dos Santos","year":"2021","journal-title":"J. Antibiot. (Tokyo)"},{"key":"B28","doi-asserted-by":"crossref","first-page":"e3000856","DOI":"10.1371\/journal.pbio.3000856","article-title":"CombiANT: antibiotic interaction testing made easy","volume":"18","author":"Fatsis-Kavalopoulos","year":"2020","journal-title":"PloS Biol."},{"key":"B29","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1155\/2008\/238585","article-title":"Nitrofurantoin-associated bronchiolitis obliterans organizing pneumonia: report of a case","volume":"15","author":"Fenton","year":"2008","journal-title":"Can. Respir. J."},{"key":"B30","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1001\/archinte.163.22.2716","article-title":"Updating the beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts","volume":"163","author":"Fick","year":"2003","journal-title":"Arch. Intern. Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1111\/j.1532-5415.2012.03923.x","article-title":"American geriatrics society updated beers criteria for potentially inappropriate medication use in older adults","volume":"60","author":"Fick","year":"2012","journal-title":"J. Am. Geriatr. Soc."},{"key":"B32","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S1473-3099(18)30279-2","article-title":"Continuous low-dose antibiotic prophylaxis for adults with repeated urinary tract infections (AnTIC): a randomised, open-label trial","volume":"18","author":"Fisher","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"B33","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrmicro3432","article-title":"Urinary tract infections: epidemiology, mechanisms of infection and treatment options","volume":"13","author":"Flores-Mireles","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1097\/MAJ.0b013e3181abd9f6","article-title":"Nitrofurantoin-induced systemic inflammatory response syndrome","volume":"338","author":"Forster","year":"2009","journal-title":"Am. J. Med. Sci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2139\/ssrn.4200934","article-title":"Combination of isothiocyanates and antibiotics increases susceptibility against Acinetobacter baumannii, Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis and Serratia marcescens","author":"Frank","year":"2022","journal-title":"Escherichia Coli Klebsiella Pneumoniae Proteus Mirabilis Serratia Marcescens"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.1093\/jac\/dkw212","article-title":"Pharmacodynamics and differential activity of nitrofurantoin against ESBL-positive pathogens involved in urinary tract infections","volume":"71","author":"Fransen","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"B37","doi-asserted-by":"publisher","first-page":"3366","DOI":"10.1093\/jac\/dkx313","article-title":"Pharmacodynamics of nitrofurantoin at different pH levels against pathogens involved in urinary tract infections","volume":"72","author":"Fransen","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"key":"B38","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/j.1469-0691.2007.01852.x","article-title":"Other antimicrobials of interest in the era of extended-spectrum \u03b2-lactamases: fosfomycin, nitrofurantoin and tigecycline","volume":"14","author":"Garau","year":"2008","journal-title":"Clin. Microbiol. Infect."},{"key":"B39","doi-asserted-by":"publisher","first-page":"14","DOI":"10.18773\/austprescr.2019.002","article-title":"Nitrofurantoin and fosfomycin for resistant urinary tract infections: old drugs for emerging problems","volume":"42","author":"Gardiner","year":"2019","journal-title":"Aust. Prescr."},{"key":"B40","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1055\/s-0041-1731106","article-title":"Nitrofurantoin susceptibility pattern in gram-negative urinary isolates: in need of increased vigilance","volume":"13","author":"Gautam","year":"2021","journal-title":"J. Lab. Physicians"},{"key":"B41","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1590\/0037-8682-0227-2017","article-title":"Clonal relation and antimicrobial resistance pattern of extended-spectrum \u03b2-lactamase- and AmpC \u03b2-lactamase-producing Enterobacter spp. isolated from different clinical samples in Tehran, Iran","volume":"51","author":"Ghanavati","year":"2018","journal-title":"Revista da Sociedade Brasileira de Medicina Tropical"},{"key":"B42","doi-asserted-by":"publisher","first-page":"180","DOI":"10.2174\/1574891X13666180517075803","article-title":"Evaluation  of fosfomycin activity against extended spectrum beta lactamase (ESBL) producing Enterobacteriaceae isolated from three centers of Tehran, Iran. Recent patents on anti-infective","volume":"13","author":"Ghanavati","year":"2018","journal-title":"Drug Discov"},{"key":"B43","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1093\/ajhp\/36.3.342","article-title":"Drug therapy reviews: nitrofurantoin","volume":"36","author":"Gleckman","year":"1979","journal-title":"Am. J. Hosp. Pharm."},{"key":"B44","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/S1473-3099(17)30344-4","article-title":"Antibiotic stewardship hits a home run for patients","volume":"17","author":"Goff","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"B45","first-page":"24","article-title":"Pulmonary reactions with nitrofurantoin","volume":"23","author":"Guidance","year":"2002","journal-title":"Prescriber Update"},{"key":"B46","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1001\/archinte.167.20.2207","article-title":"Short-course nitrofurantoin for the treatment of acute uncomplicated cystitis in women","volume":"167","author":"Gupta","year":"2007","journal-title":"Arch. Intern. Med."},{"key":"B47","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1093\/cid\/ciq257","article-title":"International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the infectious diseases society of America and the European society for microbiology and infectious diseases","volume":"52","author":"Gupta","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"B48","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1056\/NEJMra2111003","article-title":"Fever of unknown origin","volume":"386","author":"Haidar","year":"2022","journal-title":"New Engl. J. Med."},{"key":"B49","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1128\/AAC.02156-15","article-title":"Plasmid-mediated OqxAB is an important mechanism for nitrofurantoin resistance in Escherichia coli","volume":"60","author":"Ho","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"B50","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.patbio.2006.07.016","article-title":"[Uncomplicated urinary tract infections, what about fosfomycin and nitrofurantoin in 2006?]","volume":"54","author":"Honderlick","year":"2006","journal-title":"Pathol. Biol. (Paris)"},{"key":"B51","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1001\/jama.1995.03520250057034","article-title":"Randomized comparative trial and cost analysis of 3-day antimicrobial regimens for treatment of acute cystitis in women","volume":"273","author":"Hooton","year":"1995","journal-title":"Jama"},{"key":"B52","doi-asserted-by":"publisher","first-page":"630","DOI":"10.3390\/antibiotics9090630","article-title":"Current antibiotic resistance trends of uropathogens in central Europe: survey from a tertiary hospital urology department 2011-2019","volume":"9","author":"Hrbacek","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"B53","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1093\/jac\/dkv147","article-title":"Nitrofurantoin revisited: a systematic review and meta-analysis of controlled trials","volume":"70","author":"Huttner","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1001\/jama.2018.3627","article-title":"Effect of 5-day nitrofurantoin vs single-dose fosfomycin on clinical resolution of uncomplicated lower urinary tract infection in women: a randomized clinical trial","volume":"319","author":"Huttner","year":"2018","journal-title":"Jama"},{"key":"B55","doi-asserted-by":"publisher","first-page":"bcr2013203136","DOI":"10.1136\/bcr-2013-203136","article-title":"Nitrofurantoin immune-mediated drug-induced liver injury: a serious complication of a commonly prescribed medication","volume":"2014","author":"Hydes","year":"2014","journal-title":"Case Rep."},{"key":"B56","first-page":"67","article-title":"A trial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy with co-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection","author":"Iravani","year":"1999","journal-title":"J. Antimicrob. Chemother."},{"key":"B57","first-page":"1729","article-title":"Effect of propantheline on nitrofurantoin absorption","volume-title":"J. Pharm. Sci.","author":"Jaffe","year":"1975"},{"key":"B58","doi-asserted-by":"publisher","first-page":"362","DOI":"10.4212\/cjhp.v64i5.1072","article-title":"Nitrofurantoin-induced pulmonary reaction involving respiratory symptoms: case report","volume":"64","author":"Kanji","year":"2011","journal-title":"Can. J. Hosp. Pharm."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1111\/j.1464-410X.2008.07809.x","article-title":"Nitrofurantoin: the return of an old friend in the wake of growing resistance","volume":"102","author":"Kashanian","year":"2008","journal-title":"BJU Int."},{"key":"B60","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1159\/000500311","article-title":"Phenotypic and genotypic characterization of ESBL-, AmpC-, and carbapenemase-producing  Klebsiella pneumoniae and Escherichia coli isolates","volume":"28","author":"Kazemian","year":"2019","journal-title":"Med. Princ. Pract."},{"key":"B61","doi-asserted-by":"publisher","first-page":"S1360","DOI":"10.14309\/01.ajg.0000599400.11947.cc","article-title":"2467 recognizing macrobid as a potential cause for major liver injury","volume":"114","author":"Khan","year":"2019","journal-title":"Off. J. Am. Coll. Gastroenterol. ACG"},{"key":"B62","first-page":"2605","article-title":"Antibacterial synergy of tritirachium oryzae-produced silver nanoparticles with different antibiotics and essential oils derived from cupressus sempervirens and asteriscus graveolens (Forssk)","volume":"18","author":"Khlaifat","year":"2019","journal-title":"Trop. J. Pharm. Res."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.22207\/JPAM.16.3.13","article-title":"Antibacterial activity of silver nanoparticles synthesized by aspergillus flavusand its synergistic effect with antibiotics","volume":"16","author":"Khleifat","year":"2022","journal-title":"J. Pure Appl. Microbiol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12941-022-00526-2","article-title":"Molecular determination of O25b\/ST131 clone type among extended spectrum \u03b2-lactamases production Escherichia coli recovering from urinary tract infection isolates","volume":"21","author":"Khoshbayan","year":"2022","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"B65","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41579-020-0324-0","article-title":"Urinary tract infections: microbial pathogenesis, host-pathogen interactions and new treatment strategies","volume":"18","author":"Klein","year":"2020","journal-title":"Nat. Rev. Microbiol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1001\/archinte.1971.00310210075006","article-title":"Adverse reactions to sulfisoxazole, sulfamethoxazole, and nitrofurantoin. manifestations and specific reaction rates during 2,118 courses of therapy","volume":"128","author":"Koch-Weser","year":"1971","journal-title":"Arch. Intern. Med."},{"key":"B67","doi-asserted-by":"crossref","first-page":"5197","DOI":"10.1038\/s41598-022-09222-9","article-title":"Prevalence of and factors associated with atypical presentation in bacteremic urinary tract infection","volume":"12","author":"Komagamine","year":"2022","journal-title":"Sci. Rep."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1093\/jac\/dku494","article-title":"Pharmacodynamic studies of nitrofurantoin against common uropathogens","volume":"70","author":"Komp Lindgren","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"B69","doi-asserted-by":"publisher","first-page":"592","DOI":"10.4161\/viru.22364","article-title":"Molecular blueprint of uropathogenic Escherichia coli virulence provides clues toward the development of anti-virulence therapeutics","volume":"3","author":"Kostakioti","year":"2012","journal-title":"Virulence"},{"key":"B70","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S1665-2681(19)31944-1","article-title":"Nitrofurantoin-induced lung-and hepatotoxicity","volume":"6","author":"Koulaouzidis","year":"2007","journal-title":"Ann. Hepatol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1097\/AOG.0000000000003462","article-title":"Antibiotic prophylaxis during catheter-managed postoperative urinary retention after pelvic reconstructive surgery: a randomized controlled trial","volume":"134","author":"Lavelle","year":"2019","journal-title":"Obstet. Gynecol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.anaerobe.2016.06.008","article-title":"Reclassification of clostridium difficile as clostridioides difficile (Hall and O\u2019Toole 1935) Pr\u00e9vot 1938","volume":"40","author":"Lawson","year":"2016","journal-title":"Anaerobe"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009663","article-title":"Nitrofurans: revival of an \"old\" drug class in the fight against antibiotic resistance","volume":"17","author":"Le","year":"2021","journal-title":"PloS Pathog."},{"key":"B74","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.emc.2018.06.003","article-title":"The emergency department diagnosis and management of urinary tract infection","volume":"36","author":"Long","year":"2018","journal-title":"Emerg. Med. Clin. North Am."},{"key":"B75","doi-asserted-by":"publisher","first-page":"342","DOI":"10.46747\/cfp.6705342","article-title":"Nitrofurantoin-induced liver failure: a fatal yet forgotten complication","volume":"67","author":"Luk","year":"2021","journal-title":"Can. Family Physician"},{"key":"B76","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1049\/iet-nbt.2016.0148","article-title":"Foley Catheters functionalised with a synergistic combination of antibiotics and silver nanoparticles resist biofilm formation","volume":"11","author":"Mala","year":"2017","journal-title":"IET Nanobiotechnol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1186\/s12879-016-1888-1","article-title":"Oral fosfomycin for treatment of urinary tract infection: a retrospective cohort study","volume":"16","author":"Matthews","year":"2016","journal-title":"BMC Infect. Dis."},{"key":"B78","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1155\/2001\/601743","article-title":"Susceptibility of community gram-negative urinary tract isolates to mecillinam and other oral agents","volume":"12","author":"Mazzulli","year":"2001","journal-title":"Can. J. Infect. Dis. = J. canadien Des. maladies infectieuses"},{"key":"B79","doi-asserted-by":"publisher","first-page":"480","DOI":"10.4065\/mcp.2010.0800","article-title":"Nitrofurantoin compares favorably to recommended agents as empirical treatment of uncomplicated urinary tract infections in a decision and cost analysis","volume":"86","author":"McKinnell","year":"2011","journal-title":"Mayo Clin. Proc."},{"key":"B80","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1093\/jac\/33.suppl_A.23","article-title":"Nitrofurantoin: mechanism of action and implications for resistance development in common uropathogens","author":"McOsker","year":"1994","journal-title":"J. Antimicrob. Chemother."},{"key":"B81","first-page":"66","article-title":"Detection of extended spectrum beta lactamases on class I integron in Escherichia coli isolated from clinical samples","volume":"26","author":"Mohebi","year":"2016","journal-title":"J. Mazandaran Univ. Med. Sci."},{"key":"B82","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.apjtb.2015.09.024","article-title":"Evaluation of antibacterial activity and synergistic effect between antibiotic and the essential oils of some medicinal plants","volume":"6","author":"Moussaoui","year":"2016","journal-title":"Asian Pacif. J. Trop. Biomed."},{"key":"B83","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.cmi.2016.08.003","article-title":"Nitrofurantoin's efficacy and safety as prophylaxis for urinary tract infections: a systematic review of the literature and meta-analysis of controlled trials","volume":"23","author":"Muller","year":"2017","journal-title":"Clin. Microbiol. Infect."},{"key":"B84","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3390\/antibiotics3010039","article-title":"Role of old antibiotics in the era of antibiotic resistance. highlighted nitrofurantoin for the treatment of lower urinary tract infections","volume":"3","author":"Munoz-Davila","year":"2014","journal-title":"Antibiotics (Basel)"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.eururo.2008.05.010","article-title":"Surveillance study in Europe and Brazil on clinical aspects and antimicrobial resistance epidemiology in females with cystitis (ARESC): implications for empiric therapy","volume":"54","author":"Naber","year":"2008","journal-title":"Eur. Urol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1002\/cpt1979256857","article-title":"Effect of magnesium trisilicate on nitrofurantoin absorption","volume":"25","author":"Naggar","year":"1979","journal-title":"Clin. Pharmacol. Ther."},{"key":"B87","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jiac.2020.09.026","article-title":"In vitro and in vivo antibacterial activity of nitrofurantoin against clinical isolates of e. coli in Japan and evaluation of biological cost of nitrofurantoin resistant strains using a mouse urinary tract infection model","volume":"27","author":"Nakagawa","year":"2021","journal-title":"J. Infect. Chemother."},{"key":"B88","volume-title":"LiverTox: clinical and research information on drug-induced liver injury","year":"2017"},{"key":"B89","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1080\/10934529.2018.1558892","article-title":"Evaluation of antibacterial efficacy of sulfur nanoparticles alone and in combination with antibiotics against multidrug-resistant uropathogenic bacteria","volume":"54","author":"Paralikar","year":"2019","journal-title":"J. Environ. Sci. Health Part A"},{"key":"B90","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1592\/phco.30.1.57","article-title":"Drug fever","volume":"30","author":"Patel","year":"2010","journal-title":"Pharmacotherapy"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta22240","article-title":"Continuous low-dose antibiotic prophylaxis to prevent urinary tract infection in adults who perform clean intermittent self-catheterisation: the AnTIC RCT","volume":"22","author":"Pickard","year":"2018","journal-title":"Health Technol. Assess."},{"key":"B92","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1309\/BWQKWB2WN6W5X1CC","article-title":"Cross-class resistance to non-beta-lactam antimicrobials in extended-spectrum beta-lactamase-producing klebsiella pneumoniae","volume":"120","author":"Procop","year":"2003","journal-title":"Am. J. Clin. Pathol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"13256","DOI":"10.1074\/jbc.M409652200","article-title":"Structural and mechanistic studies of Escherichia coli nitroreductase with the antibiotic nitrofurazone. reversed binding orientations in different redox states of the enzyme","volume":"280","author":"Race","year":"2005","journal-title":"J. Biol. Chem."},{"key":"B94","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.urols.2016.07.004","article-title":"Risks of long-term use of nitrofurantoin for urinary tract prophylaxis in the older patient","volume":"27","author":"Rego","year":"2016","journal-title":"Urol. Sci."},{"key":"B95","first-page":"2223","article-title":"Approach to the adult patient with fever of unknown origin","volume":"68","author":"Roth","year":"2003","journal-title":"Am. Fam Physician"},{"key":"B96","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/SMJ.0000000000000059","article-title":"Nitrofurantoin-induced hepatotoxicity: a rare yet serious complication","volume":"107","author":"Sakaan","year":"2014","journal-title":"South Med. J."},{"key":"B97","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.1128\/AAC.02897-15","article-title":"Antibiotic resistance among urinary isolates from female outpatients in the united states in 2003 and 2012","volume":"60","author":"Sanchez","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"B98","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1093\/jac\/dkn222","article-title":"Nitrofurantoin resistance mechanism and fitness cost in Escherichia coli","volume":"62","author":"Sandegren","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0172273","article-title":"Synergistic interactions between phenolic compounds identified in grape pomace extract with antibiotics of different classes against Staphylococcus aureus and Escherichia coli","volume":"12","author":"Sanhueza","year":"2017","journal-title":"PloS One"},{"key":"B100","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/BF00328076","article-title":"Nitrofurantoin-resistant mutants of Escherichia coli: isolation and mapping","volume":"196","author":"Sastry","year":"1984","journal-title":"Mol. Gen. Genet."},{"key":"B101","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2217\/fmb-2017-0172","article-title":"Emerging mechanisms of antimicrobial resistance in bacteria and fungi: advances in the era of genomics","volume":"13","author":"Sekyere","year":"2018","journal-title":"Future Microbiol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"477","DOI":"10.4103\/0255-0857.167350","article-title":"Advantage and limitations of nitrofurantoin in multi-drug resistant Indian scenario","volume":"33","author":"Shakti","year":"2015","journal-title":"Indian J. Med. Microbiol."},{"key":"B103","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.4081\/cp.2012.e83","article-title":"Autoimmune hepatitis induced by nitrofurantoin. the importance of the autoantibodies for an early diagnosis of immune disease","volume":"2","author":"Sherigar","year":"2012","journal-title":"Clin. Pract."},{"key":"B104","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1093\/jac\/dkt328","article-title":"When the precautionary principle disrupts 3 years of antibiotic stewardship: nitrofurantoin in the treatment of urinary tract infections","volume":"69","author":"Slekovec","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"B105","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1016\/S0149-2918(00)86734-X","article-title":"Comparison of single-dose fosfomycin and a 7-day course of nitrofurantoin in female patients with uncomplicated urinary tract infection","volume":"21","author":"Stein","year":"1999","journal-title":"Clin. Ther."},{"key":"B106","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1080\/17425255.2016.1211110","article-title":"Autoimmune-like drug-induced liver injury: a review and update for the clinician","volume":"12","author":"Stine","year":"2016","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1001\/archneurol.2011.1120","article-title":"Peripheral nerve toxic effects of nitrofurantoin","volume":"69","author":"Tan","year":"2012","journal-title":"Arch. Neurol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"19","DOI":"10.4103\/jgid.jgid_72_17","article-title":"Nitrofurantoin and fosfomycin for extended spectrum beta-lactamases producing Escherichia coli and Klebsiella pneumoniae","volume":"10","author":"Tulara","year":"2018","journal-title":"J. Glob. Infect. Dis."},{"key":"B109","doi-asserted-by":"publisher","first-page":"439","DOI":"10.2174\/157339806778777276","article-title":"Nitrofurantoin pulmonary toxicity: a brief review","volume":"2","author":"Vahid","year":"2006","journal-title":"Curr. Respir. Med. Rev."},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0224904","article-title":"Enhancement of antibiotics antimicrobial activity due to the silver nanoparticles impact on the cell membrane","volume":"14","author":"Vazquez-Mu\u00f1oz","year":"2019","journal-title":"PloS One"},{"key":"B111","doi-asserted-by":"publisher","first-page":"7225","DOI":"10.1128\/AAC.03952-14","article-title":"An in vitro deletion in ribE encoding lumazine synthase contributes to nitrofurantoin resistance in escherichia coli","volume":"58","author":"Vervoort","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"B112","doi-asserted-by":"publisher","first-page":"205","DOI":"10.9740\/mhc.2022.06.205","article-title":"Differentiating probable nitrofurantoin-induced drug fever from antipsychotic-induced hyperthermia in a patient receiving clozapine","volume":"12","author":"Vickery","year":"2022","journal-title":"Ment. Health Clin."},{"key":"B113","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/j.freeradbiomed.2007.12.013","article-title":"Role of cytochrome P450 reductase in nitrofurantoin-induced redox cycling and cytotoxicity","volume":"44","author":"Wang","year":"2008","journal-title":"Free Radic. Biol. Med."},{"key":"B114","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.1093\/jac\/dky255","article-title":"Review of the pharmacokinetic properties of nitrofurantoin and nitroxoline","volume":"73","author":"Wijma","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.26882","article-title":"An unusual case of drug-induced liver injury secondary to nitrofurantoin use","volume":"14","author":"Wonnacott","year":"2022","journal-title":"Cureus"},{"key":"B116","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.ijantimicag.2005.08.003","article-title":"Antibiotic resistance in outpatient urinary isolates: final results from the north American urinary tract infection collaborative alliance (NAUTICA)","volume":"26","author":"Zhanel","year":"2005","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.608547","article-title":"Nitrofurantoin combined with amikacin: a promising alternative strategy for combating MDR uropathogenic Escherichia coli","volume":"10","author":"Zhong","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1128\/AAC.03502-14","article-title":"Synergistic interactions of vancomycin with different antibiotics against Escherichia coli: trimethoprim and nitrofurantoin display strong synergies with vancomycin against wild-type e. coli","volume":"59","author":"Zhou","year":"2015","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2023.1148603\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T16:57:46Z","timestamp":1690477066000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2023.1148603\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,27]]},"references-count":118,"alternative-id":["10.3389\/fcimb.2023.1148603"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2023.1148603","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,27]]},"article-number":"1148603"}}